Where I see patients (1)
My reviews
Selected research
-
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
-
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.
Genome medicine
-
Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapies.
bioRxiv : the preprint server for biology
Clinical trials
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Time to reach a durable COVID-19 level 4 or less or discharge at COVID-level 4 or lower (except for discharge to another hospital), and time to death (mortality). Data will be analyzed for 3 groups: - All - COVID-19 level...
Recruiting
My work
Cutting-edge breast cancer care
Learn about the latest findings on breast cancer risk, screening and treatment from Dr. Esserman.
Should low-risk tumors still be called cancer?
Dr. Esserman explains how using a different term could reduce unnecessary worry over cancers that are unlikely to be life-threatening.
4.9